Zentiva recalls Fingolimod 0.5 mg Capsules due to contamination risk
Zentiva UK Pharma Limited is recalling one batch of Fingolimod Zentiva 0.5 mg Capsules due to potential contamination with metal particles.
Asset / Drug
Drug and asset intelligence for Zentiva with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.